These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16150930)

  • 1. Vascular targeting of ocular neovascularization with a vascular endothelial growth factor121/gelonin chimeric protein.
    Akiyama H; Mohamedali KA; E Silva RL; Kachi S; Shen J; Hatara C; Umeda N; Hackett SF; Aslam S; Krause M; Lai H; Rosenblum MG; Campochiaro PA
    Mol Pharmacol; 2005 Dec; 68(6):1543-50. PubMed ID: 16150930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.
    Hsu AR; Cai W; Veeravagu A; Mohamedali KA; Chen K; Kim S; Vogel H; Hou LC; Tse V; Rosenblum MG; Chen X
    J Nucl Med; 2007 Mar; 48(3):445-54. PubMed ID: 17332623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.
    Mohamedali KA; Poblenz AT; Sikes CR; Navone NM; Thorpe PE; Darnay BG; Rosenblum MG
    Cancer Res; 2006 Nov; 66(22):10919-28. PubMed ID: 17108129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
    Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
    Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
    Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans-scleral delivery of polyamine analogs for ocular neovascularization.
    Lima e Silva R; Kachi S; Akiyama H; Shen J; Hatara MC; Aslam S; Gong YY; Khu NH; Lauer TW; Hackett SF; Marton LJ; Campochiaro PA
    Exp Eye Res; 2006 Nov; 83(5):1260-7. PubMed ID: 16950258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors.
    Veenendaal LM; Jin H; Ran S; Cheung L; Navone N; Marks JW; Waltenberger J; Thorpe P; Rosenblum MG
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7866-71. PubMed ID: 12060733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys.
    Lai CM; Shen WY; Brankov M; Lai YK; Barnett NL; Lee SY; Yeo IY; Mathur R; Ho JE; Pineda P; Barathi A; Ang CL; Constable IJ; Rakoczy EP
    Mol Ther; 2005 Oct; 12(4):659-68. PubMed ID: 16023893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive angiogenesis imaging of orthotopic bladder tumors in mice using a selective magnetic resonance imaging contrast agent containing VEGF121/rGel.
    Cho EJ; Yang J; Mohamedali KA; Lim EK; Kim EJ; Farhangfar CJ; Suh JS; Haam S; Rosenblum MG; Huh YM
    Invest Radiol; 2011 Jul; 46(7):441-9. PubMed ID: 21512397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
    Zhang M; Yang Y; Yan M; Zhang J
    Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of biologically active VEGF121 fusion proteins in Escherichia coli.
    Kim S; Mohamedali KA; Cheung LH; Rosenblum MG
    J Biotechnol; 2007 Feb; 128(3):638-47. PubMed ID: 17218033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1.
    Shen J; Samul R; Silva RL; Akiyama H; Liu H; Saishin Y; Hackett SF; Zinnen S; Kossen K; Fosnaugh K; Vargeese C; Gomez A; Bouhana K; Aitchison R; Pavco P; Campochiaro PA
    Gene Ther; 2006 Feb; 13(3):225-34. PubMed ID: 16195704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
    Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
    J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein.
    Keskitalo S; Tammela T; Lyytikka J; Karpanen T; Jeltsch M; Markkanen J; Yla-Herttuala S; Alitalo K
    Circ Res; 2007 May; 100(10):1460-7. PubMed ID: 17478734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of mRNA of vascular endothelial growth factor in a rat model of hyperoxia-induced retinopathy].
    Zhang ZH; Jiang L; Qiao LX
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):371-4. PubMed ID: 17706045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization.
    Nambu H; Umeda N; Kachi S; Oshima Y; Akiyama H; Nambu R; Campochiaro PA
    J Cell Physiol; 2005 Jul; 204(1):227-35. PubMed ID: 15648096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization.
    Jo DH; Kim S; Kim D; Kim JH; Jon S; Kim JH
    Biomaterials; 2014 Mar; 35(9):3052-9. PubMed ID: 24388818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.